Inflammatory microenvironment and tumor necrosis factor alpha as modulators of periostin and CCN2 expression in human non-healing skin wounds and dermal fibroblasts

Matrix Biology

Volumn 43, Issue , 2015, Pages 71-84

  Elliott, Christopher G ^a   Forbes, Thomas L ^a   Leask, Andrew ^a   Hamilton, Douglas W ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

CCN2; Dermal fibroblasts; Matricellular; Non healing wound; Periostin; Tumor necrosis factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN GEL; COLLAGEN TYPE 1; COLLAGEN TYPE 1 A2; CONNECTIVE TISSUE GROWTH FACTOR; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; CTGF PROTEIN, HUMAN; POSTN PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CELL DIFFERENTIATION; CELL INFILTRATION; CELL POPULATION; CHRONIC WOUND; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; KERATINOCYTE; MACROPHAGE; MALE; MIDDLE AGED; MYOFIBROBLAST; NEUTROPHIL CHEMOTAXIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SKIN FIBROBLAST; SKIN INJURY; WOUND HEALING; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; INJURIES; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

MURINAE;

CELL ADHESION MOLECULES; CELL PROLIFERATION; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MACROPHAGES; SKIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 84930181347     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.03.003     Document Type: Article

References (46)

1. Midwood K.S., Williams L.V., Schwarzbauer J.E. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 2004, 36:1031-1037.
2. Sgonc R., Gruber J. Age-related aspects of cutaneous wound healing: a mini-review. Gerontology 2013, 59:159-164.
3. Zgheib C., Xu J., Liechty K.W. Targeting inflammatory cytokines and extracellular matrix composition to promote wound regeneration. Adv Wound Care (New Rochelle) 2014, 3:344-355.
4. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J Cell Biol 1995, 130:503-506.
5. Elliott C.G., Hamilton D.W. Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?. J Cell Commun Signal 2011, 5(4):301-315.
6. Hamilton D.W. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal 2008, 2:9-17.
7. Shi-wen X., Stanton L.A., Kennedy L., Pala D., Chen Y., Howat S.L., et al. CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem 2006, 281:10715-10726.
8. Zhou H.M., Wang J., Elliott C., Wen W., Hamilton D.W., Conway S.J. Spatiotemporal expression of periostin during skin development and incisional wound healing: lessons for human fibrotic scar formation. J Cell Commun Signal 2010, 4:99-107.
9. Elliott C.G., Kim S.S., Hamilton D.W. Functional significance of periostin in excisional skin repair: is the devil in the detail?. Cell Adh Migr 2012, 6:319-326.
10. Elliott C.G., Wang J., Guo X., Xu S.W., Eastwood M., Guan J., et al. Periostin modulates myofibroblast differentiation during full-thickness cutaneous wound repair. J Cell Sci 2012, 125:121-132.
11. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003, 200:500-503.
12. Desmouliere A., Chaponnier C., Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005, 13:7-12.
13. Liu S., Shi-wen X., Abraham D.J., Leask A. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum 2011, 63:239-246.
14. Liu S., Taghavi R., Leask A. Connective tissue growth factor is induced in bleomycin-induced skin scleroderma. J Cell Commun Signal 2010, 4:25-30.
15. Kennedy L., Liu S., Shi-Wen X., Chen Y., Eastwood M., Sabetkar M., et al. CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res 2007, 313:952-964.
16. Tsang M., Leask A. CCN2 is required for recruitment of Sox2-expressing cells during cutaneous tissue repair. J Cell Commun Signal 2014, [Epub ahead of print].
17. Liu S., Thompson K., Leask A. CCN2 expression by fibroblasts is not required for cutaneous tissue repair. Wound Repair Regen 2014, 22:119-124.
18. Elliott C.G., Hamilton D.W. Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?. J Cell Commun Signal 2011, 5:301-315.
19. Damoiseaux J.G., Dopp E.A., Calame W., Chao D., MacPherson G.G., Dijkstra C.D. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 1994, 83:140-147.
20. Pepe D., Elliott C.G., Forbes T., Hamilton D.W. Detection of galectin-3 and localization of advanced glycation end products (AGE) in human chronic skin wounds. Histol Histopathol 2013, 29(2):251-258.
21. Rios H.F., Ma D., Xie Y., Giannobile W.V., Bonewald L.F., Conway S.J., et al. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol 2008, 79:1480-1490.
22. Wen W., Chau E., Jackson-Boeters L., Elliott C., Daley T.D., Hamilton D.W. TGF-beta and FAK regulate periostin expression in PDL fibroblasts. J Dent Res 2010, 89:1439-1443.
23. Rittie L., Perbal B., Castellot J.J., Orringer J.S., Voorhees J.J., Fisher G.J. Spatial-temporal modulation of CCN proteins during wound healing in human skin in vivo. J Cell Commun Signal 2011, 5:69-80.
24. Jackson-Boeters L., Wen W., Hamilton D.W. Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair. J Cell Commun Signal 2009, 3:125-133.
25. Nishiyama T., Kii I., Kashima T.G., Kikuchi Y., Ohazama A., Shimazaki M., et al. Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing. PLoS One 2011, 6:e18410.
26. Kapoor M., Liu S., Huh K., Parapuram S., Kennedy L., Leask A. Connective tissue growth factor promoter activity in normal and wounded skin. Fibrogenesis Tissue Repair 2008, 1:3.
27. Leask A., Abraham D.J. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 2003, 81:355-363.
28. Chen S.M., Ward S.I., Olutoye O.O., Diegelmann R.F., Kelman Cohen I. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen 1997, 5:23-32.
29. Cowin A.J., Hatzirodos N., Rigden J., Fitridge R., Belford D.A. Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid. Wound Repair Regen 2006, 14:421-426.
30. Trengove N.J., Bielefeldt-Ohmann H., Stacey M.C. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000, 8:13-25.
31. Wallace H.J., Stacey M.C. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol 1998, 110:292-296.
32. Abraham D.J., Shiwen X., Black C.M., Sa S., Xu Y., Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 2000, 275:15220-15225.
33. Goldberg M., Han Y., Yan C., Shaw M. TNF-α suppresses α-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing. J Invest Dermatol 2007, 127(11):2645-2655.
34. Padial-Molina M., Volk S.L., Rodriguez J.C., Marchesan J.T., Galindo-Moreno P., Rios H.F. Tumor necrosis factor-alpha and porphyromonas gingivalis lipopolysaccharides decrease periostin in human periodontal ligament fibroblasts. J Periodontol 2013, 84:694-703.
35. Verrecchia F., Mauviel A. TGF-beta and TNF-alpha: antagonistic cytokines controlling type I collagen gene expression. Cell Signal 2004, 16:873-880.
36. Diegelmann R.F. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen 2003, 11:490-495.
37. MacKinnon A.C., Farnworth S.L., Hodkinson P.S., Henderson N.C., Atkinson K.M., Leffler H., et al. Regulation of alternative macrophage activation by galectin-3. J Immunol 2008, 180:2650-2658.
38. Assoian R.K., Fleurdelys B.E., Stevenson H.C., Miller P.J., Madtes D.K., Raines E.W., et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A 1987, 84:6020-6024.
39. Brem H., Stojadinovic O., Diegelmann R.F., Entero H., Lee B., Pastar I., et al. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol Med 2007, 13:30-39.
40. Xu W., Jia S., Xie P., Zhong A., Galiano R.D., Mustoe T.A., et al. The expression of proinflammatory genes in epidermal keratinocytes is regulated by hydration status. J Invest Dermatol 2014, 134:1044-1055. [quiz e15.].
41. Cooker L.A., Peterson D., Rambow J., Riser M.L., Riser R.E., Najmabadi F., et al. TNF-alpha, but not IFN-gamma, regulates CCN2 (CTGF), collagen type I, and proliferation in mesangial cells: possible roles in the progression of renal fibrosis. Am J Physiol Renal Physiol 2007, 293:F157-F165.
42. Telgenhoff D., Shroot B. Cellular senescence mechanisms in chronic wound healing. Cell Death Differ 2005, 12:695-698.
43. Brem H., Golinko M.S., Stojadinovic O., Kodra A., Diegelmann R.F., Vukelic S., et al. Primary cultured fibroblasts derived from patients with chronic wounds: a methodology to produce human cell lines and test putative growth factor therapy such as GMCSF. J Transl Med 2008, 6:75.
44. Liu S., Kapoor M., Shi-wen X., Kennedy L., Denton C.P., Glogauer M., et al. Role of Rac1 in a bleomycin-induced scleroderma model using fibroblast-specific Rac1-knockout mice. Arthritis Rheum 2008, 58:2189-2195.
45. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
46. Shi-Wen X., Chen Y., Denton C.P., Eastwood M., Renzoni E.A., Bou-Gharios G., et al. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell 2004, 15:2707-2719.